Messaggio
Stampa
Bibliografia sugli psicostimolanti
in ordine alfabetico

inseriti al 04/09/2008 n° 179  titoli


THE STIMULANTS REVISITED - References

  1. Abikoff H, Gittelman R: The normalizing effects of methylphenidate on the classroom behavior of ADHD children. J. Abnorm Child Psychol 13:3-44, 1985
  2. Abikoff H, Hechtman L: Advanced topics in psychopharmacology: Multimodal treatment. In Scientific Proceedings of the American Academy of Child and Adolescent Psychiatry. New Orleans, American Academy of Child and Adolescent Psychiatry, 1995 
  3. Alles CA: The comparative physiological action of phenylethanolamine. J Pharmacol Exp Ther 32:121-128, 1928 
  4. Aman M: Recent studies in psychopharmacology in mental retardation. In Bray N (ed): International Review of Research in Mental Retardation. New York, Academic Press, 1997, pp 113-146 
  5. Aman M, Kem R, Osbome P, et al: Fenfluramine and methylphenidate in children with mental retardation and borderline IQ: Clinical effects. Am J Ment Retard 101:521- 534, 1997 
  6. Aman MG, ,Marks RE, Turbott SH, et al: Clinical effects of methylphenidate and thioridazine in intellectually subaverage children. J Am Acad Child Adolesc Psychiatry 30:246-256, 1991 
  7. Angrist B, Corwin J, Bartlik B: Early phamacokinetics and clinical effects of oral d-amphetamine in normal subjects. Biol Psychiatry 22:1357-1368, 1987 
  8. Anngard E, Cunne LM, Jonsson L: Pharmacokinetic and clinical studies on amphetamine dependent subjects. Eur J Clin Pharmacol 3:3-11, 1970 
  9. Barkley RA: A review of stimulant drug research with hyperactive children. J Child Psychol Psichiatry 18:137-165, 1977 
  10. Barkley R.A.: The effects of methylphenidate on the interactions of preschool ADHD children with their mothers. J Am Acad Child Adolesc Psychiatry 27:336-341, 1988 
  11. Barkley RA: Hyperactive girls and boys: Stimulant drug effects on mother-child interactions. J Child Psychol Psychiatry 30:379-390, 1989 
  12. Barkley RA, Cunningham CE: The effects of methylphenidate on the mother-child interactions of hyperactive children. Arch Gen Psychiatry 36:201-208, 1979 
  13. Barkley RA, Karlsson J, Strzelecki E, et al: Effects of age and ritalin dosage on mother- child interactions of hyperactive children. J Consult Clin Psychol 52:750-758, 1984 
  14. Barkley RA, McMurray MB, Edelbrock CS, et al: Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic, placebo-controlled evaluation. Pediatrics 86:184-192, 1990 
  15. Beck L, Langford IV, Mackay M, et al: Childhood chemotherapy and later drug abuse and growth curve: A follow-up study of 30 adolescente. Am J Psychiatry 132:436--438, 1975 
  16. Biederman J, Faraone S, Milberger S, et al: A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 53:437- 446, 1996 
  17. Biederman J, Ntck E, Bostic J, et al: The naturalistic course of pharmacologic treatment of children with maniclike symptoms: A systematic chart review. J Clin Psychiatry 59:628-637,1998 
  18. Biederman J, Mick E, Bostic JQ, et al: Systematic chart review of the pharmacologic treatment of comorbid attention defìcit hyperactivity disorder in youth with bipolar disorder. J Child Adolescent Psychopharmacol 9:247-256, 1999 
  19. Biederman J, Newcorn J, Sprich S: Comorbidity of attention deficit hyperactivity disorder with conduct, depressivive anxiety, and other disorders. Am J Psychiatry 148:564-577,199
  20. Biederman J, Wilens T, Ifick E, et al: Pharmacotherapy of attention-deficit / hyperactivity disorder reduces risk for substance use disorder. Pediatrics 104:E20, 1999 
  21. Biel JM: Structure-activity relationships of amphetamine and derivatives. In Costa F, Garattini S (eds): Amphetamines and Related Compounds. New York, Raven Press, 1970, pp 3-19 
  22. Birmaher B, Creenhill LL, Cooper TB, et al: Sustained release methylphenidate: Pharmacokinetic studies in ADDH rnales. J Am Acad Child Adolesc Psychiatry 28:768-772, 1989 
  23. Birmaher B, Quintana H, Greenliill LL: Methylphenidate treatment of hvperactive autistic children. J Am Acad Child Adolesc Psychiatry 27:248-251, 1988 
  24. Bloom AS, Russell LJ, Weisskopf B, et al: Methylphenidate-induced delusional disorder in a child with attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 27:88-89, 1988 
  25. Borcherding BG, Keysor CS, Rapoport JL, et al: Motor/vocal tics and compulsive behaviors on stimulant drugs: Is there a common vulnerability? Psychiatry Res 33:83-94, 1990 
  26. Bostic J, Biederman J, Spencer T, et al: Pemoline treatment of adolescent with attention-deficit hyperactivity disorder: A ten-week controlled trial. J Child Adolesc Psychopharmacol, in press 
  27. Bradley C: The behavior of children receiving benzedrine. Am J Psychiatry 94:577- 585, 193
  28. Brown RT, Sexson SB: A controlled trial of methylphenidate in black adolescents. Clin Pediatr 27:74-81, 1988 
  29. Brown RT, Wynne ME, Slimmer LW: Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning. J Clin Psychiatry 45:473-476, 1984 
  30. Caldwell J, Sever PS: The biochemical pharmacology of abused drugs. Clin Pharmacol Ther 16:625-638, 1974 
  31. Castellanos FX, Giedd JN, Elia J, et al: Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry 36:1-8, 1997 
  32. Collier CP, Soldin SJ, Swanson JM, et al: Pemoline pharmacokinetics and long term therapy in children with attention defìcit disorder and hyperactivity. Clin Pharmacokinet 10:269-278, 1985 
  33. Conners CK: Controlled trial of methylphenidate in preschool children with minimal brain dysfunction. In Gittelman-Klein R (ed): Recent Advances in Child Psychopharmacology. New York, Human Sciences Press, 1975, pp 65-78 
  34. Coons HW, Klorman R, Borgstedt AD: Effects of methylphenidate on adolescents with a childhood history of attention defìcit disorder: II. Information processing. J Am Acad Child Adolesc Psychiatry 26:368-374, 1987 
  35. Cunningham C, Siegel L, Offord D: A developmental dose-response analysis of the effects of methylphenidate on the peer interactions of attention deficit disordered boys. J Child Psychol Psychiatry 26:955-971, 1985 
  36. DEA: Methylphenidate Review Document. Drug Enforcement Administration: Office of Diversion Control, Drug and Chemical Evaluation Section. Washington, DC, Drug Enforcement Administration, 1995 
  37. Denckla MB, Bemporad JR, MacKay MC: Tics following methylphenidate administration: A report of 20 cases. JAMA 235:1349-1351, 1976 
  38. DeVane CL: Pharmacokinetics of the selective serotonin reuptake inhibitors. J Clin Psychiatry 53:13-20, 1992 
  39. Diamond I, Tannock R, Schachar R: Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiatry 38:402-409, 1999 
  40. Dulcan M: Practice parameters for the assessment and treatment of childrem ,adolescents, and adults with attention-defìcit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36(suppl):85-121, 1997
  41. Dulcan MK: Using psychostimulants to treat behavioral disorders of children and adolescents. J Child Adolesc Psychopbannacol 1:7-20, 1990 
  42. DuPaul G : The ADHD rating scale: Normative data, reliability, and validity. Unpublished manuscript of the University of Massachusetts Medical School 1990 
  43. DuPaul GJ, Barkley RA, McMurray MB: Response of children with ADHD to methylphenidate: Interaction with internalizing symptoms. J. Am Acad Child Adolesc Psychiatry 33:894-903, 1994
  44. Elia J: Stimulants and antidepressant pharmakokinetics in hyperactive children. Psychopharmacol Bull 27:411-415, 1991
  45. Elia J, Borcherding BG, Potter WZ, et al: Stimulant drug treatment of hyperactivity: Biochemical correlates. Clin Pharmacol Ther 48:57-66, 1990 
  46. Elia J, Borcherding BG, Rapoport JL, et al: Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders? Psychiatry Res 36:141- 155,1991  
  47. Famularo R, Fenton T- The effect of methilphenidate on school grades in children with attention deficit disorder without hyperactivity: A preliminary study. J Clin Psychiatry 48:112-114, 1987
  48. Faraone SV, Biederman J, Keenan K, et al: Separation of DSM III attention deficit disorder and conduct disorder: Evidence from a family genetic study of American child psychiatric patients. Psychol Med 21:109-121, 1991 
  49. Fawcett J, Busch KA: Stimulants in Psychiatry. In Schatzberg A, Nemeroff C (eds): Textbook of Psychopharmacology. Washington, DC, American Psychiatric Association, 1995, pp 417-435 
  50. Feldman H, Crumrine P, Handen BL,, et al: Methylphenidate in children with seizures and attention-deficit disorder. Am J Dis Child 143:1081-1086, 1989 
  51. Findling RL: Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: A case series. J Child Adolesc Psychopharmacol 6:165-175, 1996 
  52. Gadow K, Sverd J, Sprafkin J, et al: Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Arch Gen Psychiatry 56:330-336, 1999
  53. Gadow KD: Effects of stimulant drugs on academic performance in hyperactive and learning disabled children. J Learn Disabil 16:290-299, 1983 
  54. Gadow KD: Prevalence of drug treatment for hyperactivity and other childhood behavior disorders. In Gadow KD, Loney J (eds): Psychosocial Aspects of Drug Treatment for Hyperactivity. Boulder, Westview Press, 1981, pp 13-76 
  55. Gadow KD, Nolan EE, Sverd J: Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings. J Am Acad Child Adolesc Psychiatry 31:462-471, 1992 
  56. Gadow KD, Nolan EE, Sverd J, et al: Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings. J Am Acad Child Adolesc Psychiatry 29:710-718, 1990 
  57. Gadow KD, Sverd J, Sprafkin J, et al: Effícacy of methylphenidate for attention- deficit hyperaetivitv disorder in children with tic disorder. Arch Gen Psychiatry 52:444 455, 1995
  58. Gammon GD, Brown TE: Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacol 3:1-10, 1993 
  59. Geller B, Sun K, Zimerman B, et al: Complex and rapid-cycling in bipolar children and adolescents: A preliminary study. J Affect Disord 38:1-10, 1995 
  60. Gillberg C, Melander H, Knorring A, et al: Long-term stimulant treatment of children with ADHD symptoms: A randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 54:865-870, 1997 
  61. Gittelman R, Mannuzza S: Hyperactive boys almost grown up: III. Methylphenidate effects on ultimate height. Arch Gen Psychiatry 45.1131-1134, 1988 
  62. Glennon RA: Psychoactive phenylisopropylamines. In Meltzer HY (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp 1627- 1634 
  63. Coff DC, Ciraulo DA: Stimulants. In Ciraulo DA, Shader RI (eds): Clinical Manual of Chemical Dependence. Washington, DC, American Psychiatric Press, 1991, pp 233-257 
  64. Grabowski J, Roache JD, Schmitz JM, et al: Replacement medication for cocaine dependence: Methylphenidate. J Clin Psychopharmacol 17:485-488, 1997 
  65. Greenhill L, Osman B: Ritalin: Theory and Practice. New York, Mary Ann Liebert, 1999 
  66. Gross M: Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine / desipramine. Pediatrics 58:423-431, 1976 
  67. Gross-Tsur V, Manor O, Meere J, et al: Epilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective? J Pediatr 130:40-44, 1997 
  68. Gualtieri CT, Hicks RE: Neuropharmacology of methylphenidate and a neural substrate for childhood hyperactivity. Psychiatr Clin North Am 8:875-892, 1985 
  69. Gualtieri CT, Ondrusek MG, Firdey C: Attention deficit disorder in adults. Clin Neuropharmacol 8:343-356, 1985 
  70. Hagerman RJ, Murphy MA, Wittenberg MD: A controlled trial of stimulant medication in children with the fragile X syndrome. Am J Med Genet 30:377-392, 1988
  71. Handen BL, Feldman H, Cosling A, et al: Adverse side effects of methylphenidate among mentally retarded children with ADHD. J Am Acad Child Adolesc Psychiatry 30:241-245, 1991 
  72. Handen BL, Janoskv j, McAuliffe S, et al: Prediction of response to methylphenidate among children with ADHD and mental retardation. J Am Acad Child Adolesc Psychiatry 33:1185-1193,1994
  73. Hechtrnan L: Adolescent outcome of hyperactive children treated with stimulants in childhood: A review Psychopharmacol Bull 21:178-191, 1985
  74. Hinshaw 5, Heller T, McHale J: Covert antisocial behavior in boys with attention- deficit hyperactivity, disorder: External validation and effects of methylphenidate. J Consult Clin Psychol 60:274-281, 1992 
  75. Hinshaw S, Lee S: Ritalin effects on aggression and antisocial behavior. In Greenhill L, Osman B (eds): Ritalin: Theory and Practice. New York, Mary Ann Liebert, 1999, pp 237-264 
  76. Hinshaw SP, Buhrmester D. Heller T. Anger control in response to verbal provocation: Effects of stimulant medication for boys with ADHD. J Abnorm Child Psychol 17:393-407, 1989 
  77. Hoffinan BB, Lefkowitz RJ: Catecholamines and sympathomimetic drugs. In Gilman AC, Rall TW, Nies AS, et al (eds): The Pharmacological Basis of Therapeutics. New York, Pergamon Press, 1990, pp 187-220 
  78. Hubbard JW, Srinivas NR, Quinn D, et al: Enantioselective aspects of the disposition of dl-threo-methylphenidate after the administration of a sustained-release formulation to children with attention deficit disorder. J Pharmacol Sci 78:944-947, 1989
  79. Iaboni F, Bouffard R, Minde K, et al: The efficacy of methylphenidate in treating adults with attention-deficit/hyperactivity disorder. In Scientific Proceedings of the American Academy of Child and Adolescent Psychiatry. Philadelphia, American Academy of Child and Adolescent Psychiatry 1996 
  80. Jaffe SL: Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD. J Am Acad Child Adolesc Psychiatry 30:773-775, 1991 
  81. Jensen P: Multimodal treatment of ADHD: Findings from the NINM collaborative study. In Scientific Proceedings of the American Academy of Child and Adolescent Psychiatry. Anaheim, American Academy of Child and Adolescent-Psychiatry 1998 
  82. Jensen P, Kettle L, Roper M, et al: Are stimulants overperscribed? Treatment of ADHD in four U.S. communities. J Am Acad Child Adolesc Psychiatry 38:797-804, 1999 
  83. Johnston C, Pelham WE, Hoza J, et al: Psychostimulant rebound in attention deficit disordered boys. J Am Acad Child Adolesc Psychiatry 27:806-810, 1988 
  84. Kelly -KL, Rapport MD, DuPaul GJ: Attention deficit disorder and methylphenidate: A multi-step analysis of dose-response effects on children cardiovascular functioning. Int Clin Psychopharmacol 3:167-181, 1988 
  85. Klein R, Mannuzza S: Hyperactive boys almost grown up. III Methylphenidate effects on ultimate height. Arch Gen Psychiatry 45:1131-1134, 1988 
  86. Klein RG: Pharmacotherapy of childhood hyperactivity: An update. In Meltzer HY (eds): Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp 1215-1225 
  87. Klein RG, Abikoff R Klass E, et al: Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry 54:1073-1080, 1997 
  88. Klein RC, Bessler ,AW: Stimulant side effects in children. In Kane JM, Lieberman JA (eds): Adverse Effects of Psychotropic Drugs. New York, Guilford Press, 1992, pp 470-496 
  89. Klorman R, Coons HW, Borgstedt AD. Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder I: Clinical fìndings. J Am Acad Child Adolesc Psychiatry 26:363-367, 1987 
  90. Koehler-Troy C, Strober M, Malenbaum R: Methylphenidate induced mania in a prepubertal child. J Clin Psychiatry 47:566-567, 1986 
  91. Konkol R, Fischer M, Newby R: Double-blind, placebo-controlled stimulant trial in children with Tourette's syndrome and ADHD: Abstract. Ann Neurol 28:424, 1990 
  92. Kramer J, Loney J, Whaley-Klahn M: The role of prescribed medication in hyperactive youths' substance use. In Scientific Proceedings of the American Psychological Association. American Psychological Association, Los Angeles, 1981 
  93. Kupietz SS, Winsberg BG, Richardson E, et al: Effects of methylphenidate dosage in hyperactive reading-disabled children: I. Behavior and cognitive performance effects. J Am Acad Child Adolesc Psychiatry 27:70-77, 1988 
  94. Lambert NM, Hartsough CS: Prospective study of tobacco smoking and substance dependencies among, samples of ADHD and non-ADHD participants. J Learn Disabil 31:533-544, 1998 
  95. Law SE, Schachar RJ: Do typical clinical diagnoses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder? J Am Acad Child Adolesc Psychiatry 38:944-951, 1999 
  96. Lerer RJ, Lerer MP: Responses of adolescents with minimal brain dysfunction to methylphenidate. J Learn Disabil 10:223-228, 1977 
  97. Levin FR, Evans SM, McDowell D, et al: Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: A pilot study. J Clin Psychiatry 58:1-21, 1997 
  98. Lipkin P, Goldstein L Adesman A: Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder. Arch Pediatr Adolesc Med 148:859-861, 1994 
  99. Loeber R, Keenan K: Interaction between conduct disorder and its comorbid conditions: Effects of age and gender. Clin Psychol Rev 14:497-523, 1994 
  100. Loney J, Kramer J, Milich RS: The hyperactive child grows up: Predictors of symptoms, delinquency and achievement at followup. In Gadow K, Loney J (eds): Psychosocial Aspects of Drug Treatment for Hyperactivity. Boulder, Westview Press, 1981, pp 381-415 
  101. MacKay MC, Beek L, Taylor R: Methylphenidate for adolescents with minimal brain dysfunction. New York State J Med 73:550-554, 1973 
  102. Manos M, Short E, Findling R: Differential effectiveness of methylphenidate and Adderall in school-age youths with attention-deficit/hyperactivity disorder, J Am Acad Child Adolesc Psychiatry 38:813-819, 1999 
  103. Markowitz J, Morrison S, DeVane C: Drug interactions with psychostimulants. Int Clin Psychopharmacol 14:1-18, 1999 
  104. Masand PS, Tesar GE: Use of stimulants in the medically ill. Psychiatr Clin North Am 19:515-547, 1996
  105. Mattes JA, Boswell L, Oliver H: Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 41:1059-1063, 1984
  106. Mayes S, Crites D, Bixler E, et al: Methylphenidate and ADHD: Influence of age, IQ, and neurodevelopmental status. Dev Med Child Neurol 36:1099-1107, 1994
  107. McBride MC, Wang DD, Torres CF: Methylphenidate in therapeutic doses does not lower seizure threshold (abstract). Ann Neurol 20:428, 1986 
  108. Musten LM, Firestone P, Pisterman S, et al: Effects of methylphenidate on preschool children with ADHD: Cognitive and behavioral functions. J Am Acad Child Adolesc Psychiatry 36:1407-1415, 1997 
  109. Page JG, Bernstein JE, Janicki RS, et al: A multi-clinic trial of pemoline in childhood hyperkineses. In Connors CK (ed): Clinical Uses of Stimulant Drugs in Children. Amsterdam, Excepta Medical, 1974, pp 98-124 
  110. Patrick K, Straughn A, Jarvi E, et al: The absorption of sustained-release methylphenidate formulations compared to an immediate-release formulation. Biopharm Drue, Dispos 10:165-171, 1989 
  111. Patrick KS, Caldwell RW, Ferris RM, et al: Pharmacology of the enantiomers of threo- methylphenidate. J Pharmocol Exp Ther 241:152-158, 1987 
  112. Patrick KS, Mueller RA, Gualtieri CT, et al: Pharmacokinetics and Actions of Methylphenidate. In Meltzer HY (eds): Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp 1387-1396 
  113. Pelham W, Burrows-Maclean L, Gnagy E: OROS methylphenidate versus t.i.d. methylphenidate in regular schools settings. In Scientifìc Proceedings of the American Academy of Child and Adolescent Psychiatry. Chicago, American Academy of Child and Adolescent Psychiatry 1999 
  114. Pelham WE, Aronoff HR, Midlam JK, et al: A comparison of Ritalin and Adderal: Efficacy and time-course in children with Attention-deficit/Hyperactivity Disorder.Pediatrics :103:1-14, 1999 
  115. Pliszka SR: Tricyclic antidepressants in the treatment of children with attention deficit disorder. J Am Acad Child Adolesc Psychiatry 26:127-132, 1987 
  116. Pliszka SR: Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry 28:882-887, 1989 
  117. Quinn D: Methylphenidate: The role of the d-Isomer. In Greenhill L, Osman B (eds): Ritalin: Theory, and Practice. New York, Mary Ann Liebert, 1999, pp 369-374 
  118. Rapoport JL, Buschsbaum MS, Zahn TP, et al: Dextroamphetamine: Cognitive and behavioral effects in normal prepubertal boys. Science 199:560-562, 1978 
  119. Rapport MD, DuPaul GJ: Hyperactivity and methylphenidate: Rate-dependent effects on attention. Int Clin Psychopharmacol 1.45-52, 1986 
  120. Rapport NM, DuPaul GJ, Kelly KL: Attention deficit hyperactivity disorder and methylphenidate: The relationship between gross body weight and drug response in children. Psychopharmacol Bull 25:285-290, 1989 
  121. Rapport MD, Jones JT, DuPaul CL et al: Attention deficit disorder and methylphenidate: Group and single-subject analyses of dose effects on attention in clinic and classroom settings. J Clin Child Psychol 16:329-338, 1987 
  122. Rapport MD, Quinn SO, DuPaul GJ, et al: Attention deficit disorder with hyperactivity and methylphenidate: The effects of dose and mastery level on children’s learning performance. J Abnorm Child Psychol 17:669-689, 1989 
  123. Rapport MD, Stoner C, DuPaul GJ, et al: Attention deficit disorder and methylphenidate: A multilevel analysis of dose-response effects on children's impulsivity across settings. j Am Acad Child Adolesc Psychiatry 27:60-69, 1988 
  124. Ratey J, Creenberg M, Lindem K: Combination of treatments for attention deficit disorders in adults. J Nerv Ment Dis 176:699-701, 1991 
  125. Riggs PD: Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry 37:331-332, 1998 
  126. Safer D, Allen P, Barr E: Depression of growth in hyperactive children on stimulant drugs. New Engl J Med 287:217-220, 1972 
  127. Safer D, Zito J: Pharmacoepidemiology of methylphenidate and other stimulants for the treatment of ADHD. In Greenhill L, Osman B (eds): Ritalin- Theory and Practice. New York, Mary Ann Liebert, 1999, pp 7-26 
  128. Safer DJ, Allen RP: Stimulant drug treatment of hyperactive adolescents. Dis Nerv Syst 36:454-457, 1975 
  129. Safer DJ, Zito JM, Fine EM: Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 98:1084-1088, 1996 
  130. Sallee F, Stffler R, Perel J, et al: Oral pemoline kinetics in hyperactive children. Clin Pharmacol Ther 37:606-609, 1985 
  131. Satterfield JH, Cantwell DP, Schell A, et al: Growth of hyperactive children treated with methylphenidate. Arch Gen Psychiatry 36:212-217, 1979 
  132. Satterfield JH, Hoppe CM, Schell AM: A prospective study of delinquency in 110 adolescent boys with attention deficit disorder and 88 normal adolescent boys. Am of Psychiatry 139:795-798, 1982 
  133. Schachar R, Tannock R: Childhood hyperactivity and psychostimulants: A review of extended treatment studies. J Child Adolesc Psychopharmacol 3:81-97, 1993 
  134. Schachar R, Tannock R, Cunningham C, et al: Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J Am Acad Child Adolesc Psychiatry 36:754-763, 1997 
  135. Schleifer N, Weiss C, Cohen N, et al: Hyperactivity in preschoolers and the effect of methylphenidate. Am J Orthopsychiatry 45:38-50, 1975 
  136. Sebrechts NM, Shaywitz SE, Shaywitz BA, et al: Components of attention, methylphenidate dosage, and blood levels and children with attention deficit disorder. Pediatrics 77:222-228, 1986 
  137. Semrud-Clikeman M, Biederman J, Sprich-Buckminster 5, et al: Comorbidity between ADDH and learning disability: A review and report in a clinical referred sample. J Am Acad Child Adolesc Psychiatrv 31:439-448 1992 
  138. Shaywitz B, Fletcher J, Holahan J, et al: Interrelationships between reading disability and attention deficit hyperactivity disorder. Child Neuropsychol 1:170-186, 1995 
  139. Shaywitz BA, Klopper JH, Cordon JW. Methylphenidate in 6-hydroxydopamine treated developing rat pups: Effects on activity and maze performance. Arch Neurol 35.463-469, 1978 
  140. Shekim WO, Asarnow RF, Hess E, et al: A clinical and demographic profìle of a sample of adults with attention deficit hyperactivity disorder, residual state. Comprehensive Psychiatry 31:416-425, 1990 
  141. Shekim WO, Asarnow RF, Hess E, et al: A clinical and demographic profile of a sample of adults with Attention Deficit Hyperactivity Disorder, residual state. Comprehensive Psychiatry 31:416-425, 1990 
  142. Shevell M, Schreiber R: Pemoline-associated hepatic failure- A critical analysis of the literature. Pediatr Neurol 16:14-16, 1996 
  143. Smith B, Pelham W, Gnagy E, et al: Equivalent effects of stimulant treatment for attention-defìcit hyperactivity disorder during childhood and adolescence. J Am Acad Child Adolesc Psychiatry 37:314-321, 1998 
  144. Solanto MV, Wender EH: Does methylphenidate constrict cognitive functioning? J Am Acad Child Adolesc Psychiatry 28:897-902, 1989 
  145. Spencer T, Biederman J, Wilens T, et al: Adults with Attention-Deficit/Hyperactivity Disorder: A controversial diagnosis. J Clin Psychiatry 59(suppl):59-68, 1998 
  146. Spencer T, Biederman J, Wilens T, et al: Pharmacotherapy of attention deficit disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35:409-432, 1996 
  147. Spencer T, Wilens T, Biederman J, et al: Effectiveness and tolerability of Adderall for ADHD in adults. In Scientific Proceedings of the American Academy of Child and Adolescent Psychiatry. Chicago, American Acaderny of Child and Adolescent Psychiatry, 1999 
  148. Spencer T, Wilens TE, Biederman J, et al: A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood onset attention deficit hyperactivity disorder. Arch Gen Psychiatry 52:434-443, 1995 
  149. Spencer TJ, Biederman J, Harding M, et al: Growth deficits in ADHD children revisited: Evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry 35:1460-1469, 1996 
  150. Sverd J Gadow KD, Nolan EE, et al: Methylphenidate in hyperactive boys with comorbid tic disorder. I. Clinic evaluations. Adv Neurol 58:271-281, 1992 
  151. Swanson J, Gupta S, Guinta D, et al: Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clin Pharmacol Ther 66:295-305, 1999 
  152. Swanson J, Lerner M, Williams L: More frequent diagnosis of attention deficit- hyperactivity disorder. N Engl J Med 333:944, 1995 
  153. Swanson J, McBumett K, Christian D, et al: Stimulant medications and the treatment of children with ADHD. Adv Clin Child Psycol 17:265-322, 1995 
  154. Swanson J, Wigal S, Greenhill L, et al: Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory, classroom setting. Psychopharmacol Bull 34:5-SAO, 1998 
  155. Swanson J, Wigal S, Greenhill L, et al: Analog classroom assessment of Adderall in children with ADHD. J Am Acad Child Adolesc Psychiatry 37:519-525, 1998 
  156. Swanson JM, Granger D, Kliewer W: Natural social behaviors in hyperactive children: Dose effects of methylphenidate. J Consult Clin Psychol 55:187-193, 1987 
  157. Tannock R, Ickowicz A, Schachar R: Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 34:886-896, 1995 
  158. Taylor E, Schachar R, Thorley C, et al: Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behavior. Psychol Med, 17:121-143, 1987 
  159. Thiele EA, Gonzalez-Heydrich J, Riviello JJ: Epilepsy in children and adolescents. Child Adolesc Psychiatr Clin North Am 8:671--694, 1999 
  160. Varley CK: Effects of methylphenidate in adolescents with attention deficit disorder. J of the American Academy of Child Psychiatry, 99:351-354, 1983 
  161. Voelker SL, Lachar D, and Gdowski CL. The personality inventory for children and response to methylphenidate: Preliminary evidence for predictive validity. J Pediatr Psychol 8:161-169, 19S3 
  162. Volkow N, Wang G, Fowler J, et al: Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155:1325-1331, l998 
  163. Volkow ND, Ding Y, Fowler JS, et al: Is methylphenidate like cocaine? Arch Gen Psychiatry 52:456-463, 1995 
  164. Wender PH, Reimherr FW, Wood D, et al: A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry 142:547-552,1985 
  165. Wender PH, Reimberr FW, Wood DR: Attention deficit disorder ('minimal brain dysfunction') in adults: A replication study of diagnosis and drug treatment. Arch Gen Psychiatry 38:449-456, 1981 
  166. Wender PH, Wood DR, Reimherr FW: Pharmacological treatment of attention deficit disorder residual type (ADD, RT, "minimal brain dysfunction", "hyperactivity") in adults. Psychopharmacol Bull 21:222-230, 1985 
  167. Werry J, Aman M: Methylphenidate and haloperidol in children. Effects on memory and activity. Arch Gen Psychiatry 32:790-795, 1975 
  168. West S, McElroy S, Strakowski S, et al: Attention deficit hyperactivity disorder in adolescent mania. Am J Psychiatry 152:271-273, 1995 
  169. Whalen C, Henker B, Swanson J, et al: Natural social behaviors in hyperactive children: Dose effects of methylphenidate. J Consult Clin Psychol 55:187-193, 1987 
  170. Whalen CK, Henker B, Dotemoto S, et al: Hyperactivity and methylphenidate: Peer interaction styles. In Gadow KD, Loney J (eds): Psychosocial Aspects of Drug Treatment for Hyperactivity. Boulder, CO, Westview Press, 1981, pp 295-324 
  171. Whalen CK, Henker B, Granger DA: Social judgement processes in hyperactive boys: Effects of methylphenidate and comparisons with normal peers. J Abnorm Child Psychol 18:297-316, 1990 
  172. Wilens T: AOD Use and Attention Deficit/Hyperactivity Disorder. Alcohol Health Res World 22:127-130,1999 
  173. Wilens T- Long-term ADHD treatment with OROS methylphenidate. In Scientific Proceedings of the American Psychiatric Association, Chicago, May 2000  
  174. Wilens T, Spencer T. Pharmacology of amphetamines. In Tarter R, Ammerman R, Ott P (eds): Handbook of Substance Abuse: Neurobehavioral Pharmacology. New York, Plenum Press, 1998, pp 501-513 
  175. Wilens TE, Biederman J: The stimulants. Psychiatr Clin North Am 15:191-222, 1992 
  176. Wilens TE, Biederman J, Spencer TJ, et al: Controlled trial of high doses of Pemoline for adults with attention-deficit/ hyperactivity disorder. J Clin Psychopbarrnacol 19:257-264, 1999 
  177. Wood DR, Reimherr FW, Wender PH, et al: Diagnosis and treatment of minimal brain dysfunction in adults. Arch Gen Psychiatry 33:1453-1460, 1976 
  178. Wozniak J, Biederman J, Kiely K, et al: Mania-like symptoms suggestive of childhood onset bipolar disorder in clinically referred children. J. Am Acad Child Adolesc Psychiatry 34:867--876, 1995 
  179. Zametkin A, Liotta W: The neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry- 59:17-23, 1998